Navigation Links
GenoLogics Releases BioVault Biospecimen Management Software in Partnership With GenVault Corporation
Date:5/27/2008

CARLSBAD, Calif., May 27 /PRNewswire/ -- GenoLogics, the leading developer of translational research informatics solutions for life sciences organizations, today announced its partnership with GenVault Corporation for its biospecimen data management system, BioVault.

"We recognize the significance of biospecimen repositories with well annotated clinical information to biomedical research and have embarked on a strategic endeavor to provide a full product line of integrated software systems", says GenoLogics' VP of Market Strategy, James DeGreef. "We are excited about releasing our first biomedical product, BioVault, which is part of our total solution to help clients better manage their biosamples and related data".

GenoLogics launched its Biomedical Informatics software solution to track observational studies, collect patient data at remote sites, provide biospecimen and clinical annotations management and facilitate researchers querying on clinical information and requesting samples. The suite is comprised of five integrated products, including BioVault for biospecimen management, which GenoLogics is partnering with GenVault, a leading vendor of biosample management solutions.

"Our experience with helping clients to stabilize their biosamples at room temperature and seamlessly manage their transport, storage and retrieval complements GenoLogics' experience in providing lab and data management software solutions to research organizations", says Dr. David Wellis, CEO of GenVault. "Our biospecimen consumable, hardware and software technologies were built to allow for full integration with software applications such as the Biomedical Informatics products GenoLogics is building".

To provide clients with highly integrated world-class solutions, GenoLogics works with several leading technology vendors as part of its partner ecosystem. "We see the GenVault technology as very synergistic with our software solutions and believe that together we are providing our clients with a technically better solution to manage their biosamples and integrate with their data management systems", says James DeGreef.

GenoLogics is developing their Biomedical Informatics product line as a complement to their existing Research Informatics product line. The biomedical and research product lines, combined with the ability to provide data warehouse services, enables GenoLogics to deploy an effective solution for clients to manage their translational research initiatives.

"Our new Biomedical Informatics product line is a strategic addition to our company's offerings, allowing us to provide a more comprehensive data management solution to our life sciences clients", says Michael Ball, CEO for GenoLogics. "The new breadth of informatics solutions provided by GenoLogics will enable our customers to pursue their translational research vision more efficiently and effectively by seamlessly connecting their biomedical and research data into one platform".

About GenoLogics

GenoLogics provides enterprise level lab and scientific data management solutions to the discovery life sciences market. Our science purposed modules are complemented by a highly configurable, integrating lab informatics platform and a broad range of professional services. The GenoLogics LIMS platform is scalable to service many different labs and sciences across an organization including genomics, proteomics and other discovery research areas. As well, our platform can provide significant value to organizations with a systems biology or translational medicine initiative. For more information, please visit http://www.genologics.com.

About GenVault

GenVault is the global leader in providing biosample workflow, transport and storage solutions for genomic medicine, discovery and identification. Today, GenVault is empowering over 150 pharmaceutical companies, medical centers, academic institutions and law enforcement agencies to more fully leverage the rapidly growing genomics industry. The company's dry-state platform enables the extraction, preservation, recovery and distribution of DNA at room temperature. Future solutions will encompass multiple storage platforms and biosample types, such as proteins and RNA. For more information visit http://www.genvault.com.

Contact info:

Bobbi Leach Anjali Kansagara

Manager, Marketing Communications Marketing Manager

GenoLogics Life Sciences Software, Inc. GenVault Corporation

250.483.7063 760.268.5200

roberta.leach@genologics.com pr@genvault.com


'/>"/>
SOURCE GenVault
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
2. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
3. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
4. Verdict One Releases Directory of Board Certified Attorneys for Consumers
5. Academy releases emergency preparedness tools to enable millions more people to shelter in place
6. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
7. MITEM Releases Blue Iris eLaborate 8.6
8. Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk
9. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
10. URAC Releases Issue Briefs Examining Stakeholders Views of Care Coordination Along the Healthcare Continuum
11. Cardiac Science Releases New Cardiac Rehabilitation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... and laboratory-grade deionized water from the same place. From 101 Water Texas, here ... Satisfaction: Patients and staff can enjoy a continuous supply of pure, fresh, oxygenated ...
(Date:4/23/2017)... CA (PRWEB) , ... April 23, 2017 , ... ... solutions and managed services announced the achievement of Cisco Select certification and SMB ... throughout the United States. , In earning the Select Certification, Altura ...
(Date:4/22/2017)... , ... April 22, 2017 ... ... of Eastern Pennsylvania has named PROSHRED® Security of Philadelphia its “Woman-Owned ... PROSHRED® Philadelphia specializes in providing information destruction , recycling, and ...
(Date:4/22/2017)... PA (PRWEB) , ... April 22, 2017 , ... ... experience to his role as Vice President of Sales and Business Development at ... key GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
(Date:4/21/2017)... ... 21, 2017 , ... An April 10 article in the Daily ... reveal a great deal about prehistoric ice-age dental practitioners and their primitive and, no ... to remove decayed dental matter, and that teeth were then filled with bitumen, a ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/19/2017)... April 19, 2017  Novartis today announced the ... Heart, Lung, and Blood Institute (NHLBI) of the ... of patients with treatment-naïve severe aplastic anemia (SAA) ... with eltrombopag at the initiation of and concurrently ... evaluated three sequential treatment groups, or cohorts. Cohort ...
Breaking Medicine Technology: